#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma Chronic inflammatory demyelinating polyradiculoneuropathy Neuroendocrine cell hyperplasia of infancy Staphylococcal infection Factor IX deficiency Cardiac amyloidosis Interstitial lung disease Philadelphia positive chronic myeloid leukaemia Non-Hodgkin's lymphoma unspecified histology indolent Oesophageal squamous cell carcinoma stage III Neuroendocrine carcinoma metastatic Ventricular fibrillation Idiopathic inflammatory myopathy Angiosarcoma metastatic Pulmonary hypertension More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Treatment Myxofibrosarcoma – Diagnostics Osteosarcoma metastatic – Treatment Stevens-Johnson syndrome – Basic Information Pleural mesothelioma malignant – Trials in Disease Congenital hypotransferrinaemia – Treatment Optic glioma Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Systemic sclerosis pulmonary – Life with Disease Alport’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cloxacillin Ezetimibe Anselamimab Loperamide Hydrochloride CYCLIZINE HYDROCHLORIDE Travoprost Levobupivacaine Hydrochloride Ustekinumab Fluvastatin Azd9550 Clozapine Valoctocogene Roxaparvovec Danicamtiv YOHIMBINE HYDROCHLORIDE Ficlatuzumab Sodium Chloride AGANIRSEN Lenalidomide Parsaclisib Hydrochloride Etamsylate More therapies…

    Learn about Your Condition

    Liver disorder Pancreatic fistula Small cell lung cancer Elderly Appendicitis Mitochondrial myopathy Kawasaki's disease HER2 protein overexpression Acne Ovarian epithelial cancer Naevoid melanoma Ischaemic stroke Gastrointestinal melanoma Factor IX deficiency Endotracheal intubation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune thrombocytopenia

  • Phase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Romiplostim
    • Prednisolone
    Germany Spain

  • Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • CC-97540
    Denmark Germany

  • Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • BUDOPRUTUG
    Bulgaria Greece Spain

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    • Warm autoimmune haemolytic anaemia
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Danazol
    Belgium Bulgaria Czechia France Germany Hungary +3

  • A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Eltrombopag
    • Entecavir
    • Ianalumab
    Austria Belgium Czechia France Germany Hungary +5

  • Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Belimumab
    France
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!